A Phase I, Multiple Dose Escalation Clinical Trial of Metatinib Tromethamine Tablet in Patients With Advanced or Metastatic Solid Tumors
Latest Information Update: 28 Jan 2016
At a glance
- Drugs Metatinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Jiangsu Simcere Pharmaceutical
- 28 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Nov 2015 Planned End Date changed from 1 Jun 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 12 Nov 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov record.